Search
Searching Ingredient for "Resveratrol" · search everything instead
37 results
-
3,5-dihydroxy-4'-methoxystilbeneIngredientCommon33626-08-3; (E)-5-(4-Methoxystyryl)benzene-1,3-diol; Desoxyrhapontigenin; RESVERATROL 4'-METHYL ETHER; 4'-O-Methylresveratrol; 4-Methoxyresveratrol; Deoxyrhapontigenin; RU7RRY3RUW; CHEMBL291501 InChIKeyIHVRWFJGOIWMGC-NSCUHMNNSA-N MW242.27 g/mol Drug-like0.812 HERBHBIN007625Formula: C15H14O3 · MW: 242.274 · Drug-likeness: 0.812
-
4-prenyldihydroresveratrolIngredientHERBHBIN010828
-
4-prenylresveratrolIngredientCommonArachidin 2; 61517-87-1; ARACHIDIN-2; CHEBI:1927; 5-[(E)-2-(4-hydroxyphenyl)ethenyl]-2-(3-methylbut-2-enyl)benzene-1,3-diol; SCHEMBL4742876; CHEMBL2230263; DTXSID50415185; BDBM50507782 InChIKeyWWFOQQIWOKJBSJ-SNAWJCMRSA-N MW296.37 g/mol Drug-like0.575 HERBHBIN010830Formula: C19H20O3 · MW: 296.366 · Drug-likeness: 0.575
-
4'-preneyl oxyresveratrolIngredientHERBHBIN010826
-
4'-prenyloxyresveratrolIngredientCommon4-Prenyloxyresveratrol; 69065-16-3; 5-[(E)-2-(2,4-dihydroxyphenyl)ethenyl]-2-(3-methylbut-2-enyl)benzene-1,3-diol; 2',3,4',5-Tetrahydroxy-4-prenylstilbene; CHEBI:1736; CHEMBL4464047; SCHEMBL25223796; DTXSID90415184; AKOS040760091 InChIKeyFEHGVKWVMWWVQZ-SNAWJCMRSA-N MW312.37 g/mol Drug-like0.504 HERBHBIN010829Formula: C19H20O4 · MW: 312.365 · Drug-likeness: 0.504
-
5'-farnesyl-3'-hydroxyresveratrolIngredientHERBHBIN011547
-
Anticancerstilbenoid pmv70p691-039IngredientCommonCHEMBL463126; BDBM50269599; 5-(gamma,gamma-dimethylallyl)-oxyresveratrol InChIKeyKYQWCQJWDVPXKY-GQCTYLIASA-N MW312.37 g/mol Drug-like0.504 HERBHBIN016359Formula: C19H20O4 · MW: 312.365 · Drug-likeness: 0.504
-
Anticancerstilbenoid pmv70p691-040IngredientCommon3-(gamma,gamma-Dimethylallyl)resveratrol; CHEMBL457145; 5-[(E)-2-[4-hydroxy-3-(3-methylbut-2-enyl)phenyl]ethenyl]benzene-1,3-diol; 3-( , -Dimethylallyl)resveratrol; 3-(dimethylallyl)resveratrol; SCHEMBL22192930; BDBM50269596; 5-{2-[4-Hydroxy-3-(3-methyl-but-2-enyl)-phenyl]-vinyl}-benzene-1,3-diol; 1,3-benzenediol, 5-[(E)-2-[4-hydroxy-3-(3-methyl-2-butenyl)phenyl]ethenyl]-; 5-{(E)-2-[4-hydroxy-3-(3-methylbut-2-en-1-yl)phenyl]vinyl}benzene-1,3-diol InChIKeyBWCJJGGZRYKPID-SNAWJCMRSA-N MW296.37 g/mol Drug-like0.575 HERBHBIN016360Formula: C19H20O3 · MW: 296.366 · Drug-likeness: 0.575
-
Anticancerstilbenoid pmv70p691-041IngredientCommonCHEMBL503412; resveratrol (E)-dehydrodimer 11-O-beta-D-glucopyranoside; DTXSID501101959; BDBM50269812; 328090-92-2; 3-[(2S,3S)-5-[(1E)-2-(3,5-Dihydroxyphenyl)ethenyl]-2,3-dihydro-2-(4-hydroxyphenyl)-3-benzofuranyl]-5-hydroxyphenyl I(2)-D-glucopyranoside InChIKeyZJIBDVBTKQSZQZ-REZQOROLSA-N MW616.62 g/mol Drug-like0.142 HERBHBIN016361Formula: C34H32O11 · MW: 616.6190000000005 · Drug-likeness: 0.142
-
Bb_nc-1760IngredientCommoncis-Piceid; 148766-36-3; CHEBI:76155; Z-PICEID; (2S,3R,4S,5S,6R)-2-[3-hydroxy-5-[(Z)-2-(4-hydroxyphenyl)ethenyl]phenoxy]-6-(hydroxymethyl)oxane-3,4,5-triol; beta-D-Glucopyranoside, 3-hydroxy-5-[(1Z)-2-(4-hydroxyphenyl)ethenyl]phenyl; (2S,3R,4S,5S,6R)-2-{3-hydroxy-5-[(Z)-2-(4-hydroxyphenyl)ethenyl]phenoxy}-6-(hydroxymethyl)oxane-3,4,5-triol; cis-Resveratrol 3-glucoside; cis-Resveratrol 3-O-glucoside; CHEMBL509386 InChIKeyHSTZMXCBWJGKHG-BUFXCDORSA-N MW390.39 g/mol Drug-like0.405 HERBHBIN017654Formula: C20H22O8 · MW: 390.3880000000001 · Drug-likeness: 0.405
-
Cis-resveratrolIngredientTrials8 Refs124Common(Z)-resveratrol; 61434-67-1; Cis resveratrol; Resveratrol, (Z)-; 5-[(Z)-2-(4-hydroxyphenyl)vinyl]benzene-1,3-diol; 5-[(Z)-2-(4-hydroxyphenyl)ethenyl]benzene-1,3-diol; cis-3,4',5-trihydroxystilbene; (Z)-3,5,4'-trihydroxystilbene; Resveratrol (Z)-form [MI] InChIKeyLUKBXSAWLPMMSZ-UPHRSURJSA-N MW228.25 g/mol Drug-like0.692 HERBHBIN020921Formula: C14H12O3 · MW: 228.247 · Drug-likeness: 0.692
-
CudraninIngredientRefs7CommonOxyresveratrol; 29700-22-9; Hydroxyresveratrol; Tetrahydroxystilbene; (E)-4-(3,5-Dihydroxystyryl)benzene-1,3-diol; trans-oxyresveratrol; 4-[(E)-2-(3,5-dihydroxyphenyl)ethenyl]benzene-1,3-diol; 4721-07-7; 1,3-Benzenediol, 4-[(1E)-2-(3,5-dihydroxyphenyl)ethenyl]-; 4-[2-(3,5-dihydroxyphenyl)ethenyl]benzene-1,3-diol InChIKeyPDHAOJSHSJQANO-OWOJBTEDSA-N MW244.25 g/mol Drug-like0.612 HERBHBIN021880Formula: C14H12O4 · MW: 244.246 · Drug-likeness: 0.612
-
DesoxyrhapontigeninIngredientCommon33626-08-3; (E)-5-(4-Methoxystyryl)benzene-1,3-diol; RESVERATROL 4'-METHYL ETHER; 4'-O-Methylresveratrol; 4-Methoxyresveratrol; Deoxyrhapontigenin; 3,5-Dihydroxy-4'-methoxystilbene; RU7RRY3RUW; CHEMBL291501 InChIKeyIHVRWFJGOIWMGC-NSCUHMNNSA-N MW242.27 g/mol Drug-like0.812 HERBHBIN023497Formula: C15H14O3 · MW: 242.274 · Drug-likeness: 0.812
-
DihydroresveratrolIngredientCommon58436-28-5; 5-[2-(4-hydroxyphenyl)ethyl]benzene-1,3-diol; 3,4',5-Trihydroxybibenzyl; 5-(4-hydroxyphenethyl)benzene-1,3-diol; Dihydro-Resveratrol; CHEBI:4582; UNII-CBY43AY0TT; MFCD25973128; CBY43AY0TT InChIKeyHITJFUSPLYBJPE-UHFFFAOYSA-N MW230.26 g/mol Drug-like0.759 HERBHBIN023972Formula: C14H14O3 · MW: 230.263 · Drug-likeness: 0.759
-
E-resveratrol 3-o-beta-d-xylopyranosideIngredientHERBHBIN025490Formula: C19H20O7
-
HydroxyresveratrolIngredientCommonOxyresveratrol; 29700-22-9; Tetrahydroxystilbene; (E)-4-(3,5-Dihydroxystyryl)benzene-1,3-diol; trans-oxyresveratrol; 4-[(E)-2-(3,5-dihydroxyphenyl)ethenyl]benzene-1,3-diol; 4721-07-7; 1,3-Benzenediol, 4-[(1E)-2-(3,5-dihydroxyphenyl)ethenyl]-; 4-[2-(3,5-dihydroxyphenyl)ethenyl]benzene-1,3-diol InChIKeyPDHAOJSHSJQANO-OWOJBTEDSA-N MW244.25 g/mol Drug-like0.612 HERBHBIN029755Formula: C14H12O4 · MW: 244.246 · Drug-likeness: 0.612
-
IsorhapontigeninIngredientRefs7Common32507-66-7; Isorhapotogenin; 3'-Methoxyresveratrol; 5-[(E)-2-(4-hydroxy-3-methoxyphenyl)ethenyl]benzene-1,3-diol; CZ49V3K5HS; (E)-5-(4-hydroxy-3-methoxystyryl)benzene-1,3-diol; 5-[2-(4-Hydroxy-3-methoxyphenyl)ethenyl]-1,3-benzenediol; 5-((1E)-2-(4-HYDROXY-3-METHOXYPHENYL)ETHENYL)-1,3-BENZENEDIOL; 5-[(1E)-2-(4-HYDROXY-3-METHOXYPHENYL)ETHENYL]-1,3-BENZENEDIOL InChIKeyANNNBEZJTNCXHY-NSCUHMNNSA-N MW258.27 g/mol Drug-like0.74 HERBHBIN031175Formula: C15H14O4 · MW: 258.273 · Drug-likeness: 0.74
-
Oxyresveratrol 2-o-beta-d-glucopyranosideIngredientCommon392274-22-5; (2S,3R,4S,5S,6R)-2-[2-[(E)-2-(3,5-dihydroxyphenyl)ethenyl]-5-hydroxyphenoxy]-6-(hydroxymethyl)oxane-3,4,5-triol; Oxyresveratrol 2-O-|A-D-glucopyranoside; (2S,3R,4S,5S,6R)-2-(2-((E)-2-(3,5-dihydroxyphenyl)ethenyl)-5-hydroxyphenoxy)-6-(hydroxymethyl)oxane-3,4,5-triol; HY-N3516; AKOS040760611; Oxyresveratrol 2-O-b-D-glucopyranoside; Oxyresveratrol 2-O-??-D-glucopyranoside; Oxyresveratrol 2-O-I2-D-glucopyranoside InChIKeyUPUMEBJDZQEUFC-CUYWLFDKSA-N MW406.39 g/mol Drug-like0.343 HERBHBIN038515Formula: C20H22O9 · MW: 406.3870000000001 · Drug-likeness: 0.343
-
Oxyresveratrol-2-o-beta-d-glucopyranosideIngredientCommonOxyresveratrol 2-O-beta-D-glucopyranoside; 392274-22-5; (2S,3R,4S,5S,6R)-2-[2-[(E)-2-(3,5-dihydroxyphenyl)ethenyl]-5-hydroxyphenoxy]-6-(hydroxymethyl)oxane-3,4,5-triol; Oxyresveratrol 2-O-|A-D-glucopyranoside; (2S,3R,4S,5S,6R)-2-(2-((E)-2-(3,5-dihydroxyphenyl)ethenyl)-5-hydroxyphenoxy)-6-(hydroxymethyl)oxane-3,4,5-triol; HY-N3516; AKOS040760611; Oxyresveratrol 2-O-b-D-glucopyranoside; Oxyresveratrol 2-O-??-D-glucopyranoside; Oxyresveratrol 2-O-I2-D-glucopyranoside InChIKeyUPUMEBJDZQEUFC-CUYWLFDKSA-N MW406.39 g/mol Drug-like0.343 HERBHBIN038514Formula: C20H22O9 · MW: 406.3870000000001 · Drug-likeness: 0.343
-
Oxyresveratrol-3'-o-beta-d-glucopyranosideIngredientCommon144525-40-6; Oxyresveratrol 3'-O-beta-D-glucopyranoside; (2S,3R,4S,5S,6R)-2-[3-[(E)-2-(2,4-dihydroxyphenyl)ethenyl]-5-hydroxyphenoxy]-6-(hydroxymethyl)oxane-3,4,5-triol; Oxyresveratrol 3'-O-|A-D-glucopyranoside; SCHEMBL22498791; DTXSID801144144; HY-N3517; AKOS040760612; FS-7122; DA-66424 InChIKeyGGQVPULXXVQLRT-CUYWLFDKSA-N MW406.39 g/mol Drug-like0.343 HERBHBIN038516Formula: C20H22O9 · MW: 406.3870000000001 · Drug-likeness: 0.343
-
Oxyresveratrol-3'-o-beta-d-glucopyranosyl-4-o-beta-d-glucopyranosyl-(1→6)-o-beta-d-glucopyranosideIngredientHERBHBIN038518
-
Oxyresveratrol-3'-o-beta-glucopyranosideIngredientHERBHBIN038519
-
Oxyresveratrol-4-o-beta-d-glucopyranosyl-3'-o-beta-d-apiofuranosyl-(1→6)-o-beta-d-glucopyranosideIngredientHERBHBIN038520
-
Oxyresveratrol-4-o-beta-d-glucopyranosyl-3'-o-beta-d-glucopyranosyl-(1→6)-o-beta-d-glucopyranosideIngredientHERBHBIN038521
-
Piceatannol 4'-o-beta-d-glucopyranosideIngredientCommon(E)-Resveratroloside; 116181-54-5; beta-D-Glucopyranoside, 4-[(1E)-2-(3,5-dihydroxyphenyl)ethenyl]-2-hydroxyphenyl; CHEMBL480100; SCHEMBL20280153; ACon1_001245; DTXSID301289066; AKOS040736249; Piceatannol 4'-O-?-D-glucopyranoside; NCGC00169538-01 InChIKeyOLCVEOSSVCAFGR-CUYWLFDKSA-N MW406.39 g/mol Drug-like0.343 HERBHBIN039823Formula: C20H22O9 · MW: 406.3870000000001 · Drug-likeness: 0.343
-
PiceidIngredientCommon27208-80-6; 65914-17-2; Trans-Piceid; 3,4,5-Trihydroxystilbene-3-beta-monoglucoside; 3,4,5-Tsg; Resveratrol 3-beta-mono-D-glucoside; Resveratrol 3-O-beta-glucopyranoside; (2S,3R,4S,5S,6R)-2-(3-Hydroxy-5-(4-hydroxystyryl)phenoxy)-6-(hydroxymethyl)tetrahydro-2H-pyran-3,4,5-triol; resveratrol 3-O-beta-D-glucoside InChIKeyHSTZMXCBWJGKHG-CUYWLFDKSA-N MW390.39 g/mol Drug-like0.405 HERBHBIN039824Formula: C20H22O8 · MW: 390.3880000000001 · Drug-likeness: 0.405
-
PolydatinIngredientMetas1 Refs24CommonPiceid; 27208-80-6; 65914-17-2; Trans-Piceid; 3,4,5-Trihydroxystilbene-3-beta-monoglucoside; 3,4,5-Tsg; Resveratrol 3-beta-mono-D-glucoside; Resveratrol 3-O-beta-glucopyranoside; (2S,3R,4S,5S,6R)-2-(3-Hydroxy-5-(4-hydroxystyryl)phenoxy)-6-(hydroxymethyl)tetrahydro-2H-pyran-3,4,5-triol; resveratrol 3-O-beta-D-glucoside InChIKeyHSTZMXCBWJGKHG-CUYWLFDKSA-N MW390.39 g/mol Drug-like0.405 HERBHBIN040403Formula: C20H22O8 · MW: 390.3880000000001 · Drug-likeness: 0.405
-
Resveratrol 3,4'-o,o'-di-beta-d-glucopyranosideIngredientHERBHBIN042114Formula: C26H32O13
-
Resveratrol e-dehydrodimerIngredientHERBHBIN042119Formula: C28H22O6
-
Resveratrol-10-c-beta-glucopyranosideIngredientHERBHBIN042112Formula: C20H22O8
-
Resveratrol-3,4'-di-o-beta-d-glucopyranosideIngredientHERBHBIN042113
-
Resveratrol-4'-o-(6''-o-galloyl)-beta-d-glucopyra-nosideIngredientCommon(E)-Resveratrol 3-(6''-galloyl)-O-beta-D-glucopyranoside; [(2R,3S,4S,5R,6S)-3,4,5-trihydroxy-6-[3-hydroxy-5-[(E)-2-(4-hydroxyphenyl)ethenyl]phenoxy]oxan-2-yl]methyl 3,4,5-trihydroxybenzoate; ((2R,3S,4S,5R,6S)-3,4,5-trihydroxy-6-(3-hydroxy-5-((E)-2-(4-hydroxyphenyl)ethenyl)phenoxy)oxan-2-yl)methyl 3,4,5-trihydroxybenzoate; RGGP CPD; CHEMBL480304 InChIKeyYGKDMUYXJBMRBO-XMPPFBFMSA-N MW542.49 g/mol Drug-like0.121 HERBHBIN042117Formula: C27H26O12 · MW: 542.4930000000004 · Drug-likeness: 0.121
-
Resveratrol-4'-o-beta-d-glucosideIngredientCommonCHEMBL1939432; BDBM50362659 InChIKeyISYJYFWUXHMCFY-YQNXQPKHSA-N MW390.39 g/mol Drug-like0.373 HERBHBIN042118Formula: C20H22O8 · MW: 390.3880000000001 · Drug-likeness: 0.373
-
Resveratrol(e)-dehydrodimer 11'-o-beta-d-gluco-pyranosideIngredientCommonSCHEMBL2542558; DTXSID101101969; 328090-94-4; 3-[(1E)-2-[(2S,3S)-3-(3,5-Dihydroxyphenyl)-2,3-dihydro-2-(4-hydroxyphenyl)-5-benzofuranyl]ethenyl]-5-hydroxyphenyl I(2)-D-glucopyranoside InChIKeyFICNVOULKMUCLH-REZQOROLSA-N MW616.62 g/mol Drug-like0.142 HERBHBIN042121Formula: C34H32O11 · MW: 616.6190000000004 · Drug-likeness: 0.142
-
Trans-3,5-dihydroxy-5-methoxy-stilbeneIngredientCommonPinostilbene; 42438-89-1; 3-methoxy-4',5-dihydroxy-trans-stilbene; Pinostilbene hydrate; 3-[(E)-2-(4-hydroxyphenyl)ethenyl]-5-methoxyphenol; trans-Pinostilbene; Pinostilbene, trans-; CHEBI:63672; resveratrol monomethyl ether; 4PAK325BEM InChIKeyKUWZXOMQXYWKBS-NSCUHMNNSA-N MW242.27 g/mol Drug-like0.812 HERBHBIN046673Formula: C15H14O3 · MW: 242.274 · Drug-likeness: 0.812
-
Trans-resveratrolIngredientTrials95 Metas84 Refs131Commonresveratrol; 501-36-0; 3,4',5-Trihydroxystilbene; (E)-5-(4-Hydroxystyryl)benzene-1,3-diol; 3,5,4'-Trihydroxystilbene; (E)-resveratrol; Resvida; 3,4',5-Stilbenetriol; 5-[(E)-2-(4-hydroxyphenyl)ethenyl]benzene-1,3-diol InChIKeyLUKBXSAWLPMMSZ-OWOJBTEDSA-N MW228.25 g/mol Drug-like0.692 HERBHBIN046831Formula: C14H12O3 · MW: 228.247 · Drug-likeness: 0.692
-
Trans-resveratrol-3-o-beta-d-glucopyranosidIngredientHERBHBIN046832